Aliphatics Expansion And EV Demand Will Support A Fairly Valued Long Term Outlook

Catalysts

About Covestro

Covestro produces high performance materials used in coatings, adhesives, foams and plastics for sectors such as mobility, construction, electronics and furniture.

What are the underlying business or industry changes driving this perspective?

• The acquisition of Pontacol and the planned purchase of two HDI derivative facilities in the U.S. and Thailand increase Covestro's footprint in coatings and adhesives for mobility, construction and furniture. This can support future revenue and EBITDA through added capacity and broader product offerings.
• Greater exposure to electric vehicles, where material content per car is described as roughly 2x to up to 5x higher than in combustion engine cars, ties the company to the long term shift toward EVs. This can lift segment revenues and support mix driven margin resilience.
• Expansion of aliphatics isocyanate capacity in the U.S. and Asia Pacific, described as attractive growth regions, positions Covestro to serve coatings and adhesives customers locally. This can help utilization rates and potentially support EBITDA margins as the new assets are absorbed.
• Expected synergies in the high double digit million euro range over the next 5 years from integrating the HDI derivative assets and applying Covestro's aliphatics technology platform target structural cost savings. This can support EBITDA and net margins even if pricing remains under pressure.
• The focus on self help through short term contingency savings and longer term structural savings, already reflected as a positive contribution in the EBITDA bridge, signals ongoing cost discipline. This can support earnings and free operating cash flow as volumes and pricing conditions evolve.

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Covestro's revenue will grow by 3.6% annually over the next 3 years.
• Analysts assume that profit margins will increase from -5.0% today to 2.0% in 3 years time.
• Analysts expect earnings to reach €285.8 million (and earnings per share of €1.51) by about March 2029, up from -€644.0 million today.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 65.3x on those 2029 earnings, up from -19.5x today. This future PE is greater than the current PE for the GB Chemicals industry at 21.4x.
• Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 5.79%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Persistent industry oversupply and the 7 percentage point pricing pressure seen in Q3 2025, with selling prices falling faster than raw material costs, could keep revenue growth subdued and limit any recovery in EBITDA margins. This would challenge the idea that the share price simply moves sideways if markets begin to price in structurally lower profitability.
• The Dormagen fire, with an estimated burden of up to €150 million on 2025 EBITDA and only a gradual ramp back to full TDI capacity during 2026, highlights operational and concentration risk in key assets. This could weigh on earnings if further disruptions or slower than expected repair progress lead investors to apply a lower earnings multiple.
• Net debt of €292 million higher than at the end of 2024 and a net debt to EBITDA ratio of 3.8x, together with negative free operating cash flow of €370 million over the first 9 months of 2025 and annual CapEx guidance of €700 million to €800 million, could pressure the balance sheet and constrain flexibility. This may affect net margins and leave the share price vulnerable if credit metrics become a concern.
• Weakness across several end markets, including low single digit to low teens volume declines in construction, electronics and furniture wood, and reduced growth forecasts for automotive, furniture and electronics, may continue to limit volume growth and pricing power. This would weigh on revenue and earnings if these conditions persist longer than the market currently assumes.
• Execution risk around acquisitions and large transactions, such as integrating Pontacol and the HDI derivative assets and completing the XRG deal amid ongoing regulatory reviews, could affect the timing and size of expected EBITDA synergies and cost savings. This may cause earnings and free operating cash flow to come in below expectations if integration or approvals are slower or more expensive than planned.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of €62.0 for Covestro based on their expectations of its future earnings growth, profit margins and other risk factors.
  
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €14.4 billion, earnings will come to €285.8 million, and it would be trading on a PE ratio of 65.3x, assuming you use a discount rate of 5.8%.
  
• Given the current share price of €60.4, the analyst price target of €62.0 is 2.6% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.